Please check your internet connection and try again.
# Walethmade%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is an anticholinergic agent.
## Primary Indications
* Management of symptoms associated with gastrointestinal tract disorders, such as spasms and cramping.
* Reduction of secretions.
## Adult Dosing
* Dosing is highly variable and depends on the specific indication and formulation.
* Typical doses may range from 5 mg to 15 mg every 4 to 6 hours as needed.
* Maximum daily doses are not well-established and depend on clinical response and tolerability. Consult local protocols for specific maximums.
## Pediatric Dosing
* Information on pediatric dosing for Walethmade%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is limited and not well-established. Use with caution and at the discretion of the prescriber.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose adjustments may be necessary, particularly in severe renal impairment.
* **Hepatic Impairment:** Use with caution. Dose adjustments may be necessary, particularly in severe hepatic impairment.
## Contraindications
* Hypersensitivity to Walethmade%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide or other anticholinergic agents.
* Conditions where anticholinergic effects are undesirable, such as:
* Glaucoma (especially angle-closure)
* Myasthenia gravis
* Obstructive uropathy (e.g., bladder neck obstruction, prostatic hypertrophy)
* Obstructive gastrointestinal disorders (e.g., paralytic ileus, pyloric stenosis)
* Uncontrolled supraventricular tachycardia
* Tachycardia secondary to thyrotoxicosis or cardiac disease
* Severe ulcerative colitis or toxic megacolon
## Adverse Effects
Common anticholinergic effects:
* Dry mouth
* Constipation
* Blurred vision
* Urinary retention
* Drowsiness, dizziness
* Tachycardia
Less common:
* Confusion, excitement (especially in elderly)
* Nausea, vomiting
* Skin rash
## Key Drug Interactions
* **Other Anticholinergic Agents (e.g., antidepressants, antihistamines, antipsychotics, other antispasmodics):** Increased risk of additive anticholinergic side effects.
* **Opioid Analgesics:** May increase the risk of severe constipation and ileus.
* **Amantadine:** Increased risk of anticholinergic toxicity.
* **Potassium Chloride:** Increased risk of gastrointestinal ulceration with extended-release formulations of potassium chloride.
## Monitoring
* Monitor for efficacy in symptom control.
* Monitor for adverse effects, particularly anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation, confusion).
* Assess for signs of paralytic ileus, especially with concomitant use of other agents causing decreased GI motility.
## Clinical Pearls
* Use the lowest effective dose to minimize anticholinergic side effects.
* Caution in elderly patients, as they are more susceptible to central nervous system effects (confusion, delirium) and anticholinergic adverse events.
* Advise patients to avoid activities requiring mental alertness if experiencing drowsiness or dizziness.
* Ensure adequate fluid and fiber intake to mitigate constipation.
***
*This information is intended for educational purposes only and does not constitute medical advice. Always verify current prescribing information with an official drug compendium or the product's labeling before making clinical decisions.*
